Patents-Review.com
ClassID:

170865 ⎘

G01N2800/323 - CPC Classification

Classification description:

Detection or diagnosis of diseases; Cardiovascular disorders Arteriosclerosis, Stenosis

Recent Application in this class:
#1
20260098305
2026-04-09

INFLAMMATORY DISEASE GENE PANEL

 #2
20260023084
2026-01-22

COMP PEPTIDE AND ANTIBODIES THERETO FOR DIAGNOSING OSTEOARTHRITIS

 #3
20250341528
2025-11-06

USE OF ANTI-CITRULLINATED PEPTIDE ANTIBODY AS BIOMARKER FOR DIAGNOSIS AND PROGNOSIS OF AORTIC VALVE STENOSIS

 #4
20250266163
2025-08-21

VULNERABLE PLAQUE ASSESSMENT AND OUTCOME PREDICTION IN CORONARY ARTERY DISEASE

 #5
20250258177
2025-08-14

MICROENVIRONMENTAL DETERMINANTS OF CLONAL HEMATOPOIESIS EXPANSION RATE

 #6
20250251393
2025-08-07

APOB:CFAS CONTENT TO AID IN THE DIAGNOSIS AND TREATMENT OF CARDIOVASCULAR DISEASES

 #7
20250231195
2025-07-17

USE OF FSH-RECEPTOR LIGANDS FOR DIAGNOSIS AND THERAPY OF ATHEROSCLEROSIS

 #8
20250207133
2025-06-26

CONSTRUCTS, VIRAL VECTORS AND PHARMACEUTICAL COMPOSITIONS COMPRISING LONG NONCODING RNA ANRIL FOR TREATMENT OF DISEASE

 #9
20240385201
2024-11-21

LIPIDOMIC BIOMARKERS FOR ATHEROSCLEROSIS AND CARDIOVASCULAR DISEASE

 #10
20240296902
2024-09-05

Methods, Systems and Computer Programs for Assessing CHD Risk Using Adjusted HDL Particle Number Measurements

 #11
20240229045
2024-07-11

Aptamer for specifically recognizing soluble ST2 protein and application of the same

 #12
20240125719
2024-04-18

NMR Quantification of TMAO

 #13
20240118288
2024-04-11

HUMORAL ANTIBODY BIOMARKER FOR DETECTING ARTERY LESIONS, AND DETECTING CEREBROVASCULAR AND CARDIOVASCULAR DISORDER, DIABETES, CHRONIC NEPHROPATHY, OR SOLID CANCER

 #14
20240044924
2024-02-08

METHOD FOR DETERMINING A LIKELIHOOD OF A SUBJECT TO RESPOND TO LIPID LOWERING THERAPY

 #15
20230417777
2023-12-28

LIPID BIOMARKERS FOR STABLE AND UNSTABLE HEART DISEASE

 #16
20230251278
2023-08-10

ACQUISITION METHOD OF VALUE RELATING TO TRIGLYCERIDE METABOLIC CAPACITY, PRESENTATION METHOD OF DISEASE INFORMATION, PRESENTATION METHOD OF DISEASE DIFFERENTIATION INFORMATION, PRESENTATION METHOD OF THERAPY EFFICACY INFORMATION, PRESENTATION METHOD OF THERAPEUTIC EFFECT INFORMATION, TEST REAGENT AND TEST KIT

 #17
20230003741
2023-01-05

METHODS AND COMPOSITIONS FOR CARDIOVASCULAR DISEASE DETECTION AND MANAGEMENT

 #18
20220290098
2022-09-15

METHOD FOR DIAGNOSING AND TREATING ATHEROSCLEROSIS BY USING NANOVESICLE TARGETING SITE OF CHANGE IN BLOOD FLOW

 #19
20220229071
2022-07-21

DIAGNOSTIC AND PROGNOSTIC METHODS FOR PERIPHERAL ARTERIAL DISEASES, AORTIC STENOSIS, AND OUTCOMES

 #20
20220205997
2022-06-30

A detection method for detecting an oxidized LDL/Beta2GPI complex and a detection kit therefor

 #21
20220196681
2022-06-23

ARTERIOSCLEROSIS AND ARTERIOSCLEROSIS-RELATED DISEASE MARKER

 #22
20220187312
2022-06-16

BIOMARKERS OF SUBCLINICAL ATHEROSCLEROSIS

 #23
20220065829
2022-03-03

TMA-formation inhibitor treatment for elevated TMA-containing compound diseases

 #24
20220026443
2022-01-27

Marker for diagnosing atherosclerosis severity, and diagnostic method using same

 #25
20210164999
2021-06-03

METHOD FOR MEASURING THE TRIMETHYLAMINE N-OXIDE PRODUCTION CAPACITY IN AN INDIVIDUAL

 #26
20210003598
2021-01-07

Lipidomic biomarkers for atherosclerosis and cardiovascular disease

 #27
20200355634
2020-11-12

NMR quantification of TMAO

 #28
20200309798
2020-10-01

METHOD FOR DETERMINING CARDIOVASCULAR RISK BY POSTPRANDIAL CHANGES IN HDL3

 #29
20200231708
2020-07-23

Polypeptides which bind C-X-C chemokine receptor type 4 (CXCR4) and methods of treating or reducing the risk of fibrosis and cancer

 #30
20200174020
2020-06-04

Method for prediction of response to cardiovascular regeneration based on detecting the amount of biomarkers

 #31
20200173979
2020-06-04

Trimethylamine compounds as risk predictors of cardiovascular disease

 #32
20200129535
2020-04-30

DESMOCOLLIN 1 INHIBITORS FOR THE PREVENTION OR TREATMENT OF ATHEROSCLEROSIS

 #33
20200115756
2020-04-16

METHOD FOR DIAGNOSIS OF UNSTABLE ATHEROSCLEROTIC PLAQUES

 #34
20200088747
2020-03-19

LIPID BIOMARKERS FOR STABLE AND UNSTABLE HEART DISEASE

 #35
20200072837
2020-03-05

METHODS FOR PREVENTING, MODULATING AND/OR REDUCING CARDIOVASCULAR DISEASE

 #36
20200066370
2020-02-27

Methods, systems and computer programs for assessing CHD risk using adjusted HDL particle number measurements

 #37
20200003762
2020-01-02

Diagnostics Platform for Mitochondrial Dysfunctions/Diseases

 #38
20200002744
2020-01-02

Measurement of Lp-PLAactivity

 #39
20190307841
2019-10-10

Use of CD24 for lowering low-density lipoprotein cholesterol levels

 #40
20190277860
2019-09-12

Method of detecting arteriosclerosis

 #41
20190257841
2019-08-22

USE OF sCD14 OR ITS FRAGMENTS OR DERIVATIVES FOR RISK STRATIFICATION, DIAGNOSIS AND PROGNOSIS

 #42
20190242915
2019-08-08

Method For Quantifying Plasmalogens Using PLA1 Processing

 #43
20190234917
2019-08-01

Trimethylamine-containing compounds for diagnosis and prediction of disease

 #44
20190177403
2019-06-13

Method of treating extracellular tissue and vascular calcification and arteriosclerosis

 #45
20190154711
2019-05-23

METHOD FOR QUANTIFYING THE AMOUNT OF CHOLESTEROL IN HIGH-DENSITY LIPOPROTEIN 3

 #46
20190137525
2019-05-09

Detection of restensosis risk in patients receiving a stent

 #47
20190137514
2019-05-09

COMPEPTIDE AND ANTIBODIES THERETO FOR DIAGNOSING OSTEOARTHRITIS

 #48
20190056413
2019-02-21

METHOD FOR DETECTING DISEASE

 #49
20190049464
2019-02-14

BLOOD BIOMARKER FOR DETECTING ARTERIOSCLEROSIS

 #50
20190032138
2019-01-31

Predictive methods of atherosclerosis and stenosis

 #51
20180372763
2018-12-27

Methods of detecting, diagnosing, and treating carotid plaque vulnerability

 #52
20180336319
2018-11-22

Learning based methods for personalized assessment, long-term prediction and management of atherosclerosis

 #53
20180321266
2018-11-08

Lipidomic biomarkers for atherosclerosis and cardiovascular disease

 #54
20180284143
2018-10-04

Method for quantifying plasmalogens using PLA1 processing

 #55
20180235919
2018-08-23

System and Method For Treating Atheroma Formation

 #56
20180211389
2018-07-26

Apparatus and method of automatic pre and post quantitative coronary angiography for qualifying an outcome of a vascular treatment

 #57
20180209991
2018-07-26

ANALYSIS FOR ATHEROSCLEROSIS

 #58
20180179584
2018-06-28

Identification of a Person having Risk for Atherosclerosis and Associated Disease by the Person's Gut Microbiome and the Prevention of such Diseases

 #59
20180172703
2018-06-21

Future cardiac event biomarkers CCL3, CCL5, and CCL18

 #60
20180156818
2018-06-07

METHODS FOR TREATMENT OF CARDIOVASCULAR DISEASE

 #61
20180110828
2018-04-26

Use of CD24 for lowering low-density lipoprotein cholesterol levels

 #62
20180073075
2018-03-15

Risk Factors of Cigarette Smoke-Induced Spriometric Phenotypes

 #63
20180072816
2018-03-15

CXCR4 binding molecules and methods of use thereof

 #64
20170369592
2017-12-28

NOVEL ANTI-FIBROBLAST ACTIVATION PROTEIN (FAP) ANTIBODIES AND USES DERIVED THEREOF

 #65
20170354129
2017-12-14

Biotinylated and oxidized LDL receptor and advanced glycation end product receptor produced using genetically engineered silkworm

 #66
20170350903
2017-12-07

Molecular flux rates through critical pathways measured by stable isotope labeling in vivo, as biomarkers of drug action and disease activity

 #67
20170328902
2017-11-16

Detection of activated monocytes in human peripheral blood and determining the concentration of cell surface integrin using plasmon amplified raman detection

 #68
20170292965
2017-10-12

Detection of restensosis risk in patients receiving a stent

 #69
20170292962
2017-10-12

Method for determining the propensity for calcification

 #70
20170184521
2017-06-29

NMR quantification of TMAO

 #71
20170083663
2017-03-23

Methods, systems and computer programs for assessing CHD risk using adjusted HDL article number measurements

 #72
20170082620
2017-03-23

C1q-ADIPONECTIN COMPLEX AND USE THEREOF

 #73
20170059595
2017-03-02

HIGH THROUGHPUT BIOCHEMICAL FLUOROMETRIC METHOD FOR MEASURING HDL REDOX ACTIVITY

 #74
20170016924
2017-01-19

METHODS FOR ASSESSING THE RISK FOR DEVELOPMENT OF CARDIOVASCULAR DISEASE

 #75
20160377632
2016-12-29

METHOD FOR DIGANOSING ATHEROSCLEROTIC PLAQUES BY MEASUREMENT OF CD36

 #76
20160375101
2016-12-29

Methods of Using Interleukin-10 for Treating Diseases and Disorders

 #77
20160370365
2016-12-22

METHOD OF EVALUATION OF THE RELATIVE RISK OF DEVELOPING ATHEROSCLEROSIS IN PATIENTS

 #78
20160363601
2016-12-15

Lipidomic biomarkers for atherosclerosis and cardiovascular disease

 #79
20160349236
2016-12-01

Trimethylamine compounds as risk predictors of cardiovascular disease

 #80
20160291034
2016-10-06

System and method for studying matrix vesicle calcification

 #81
20160187352
2016-06-30

Methods and kits for predicting the risk of having a cardiovascular disease or event

 #82
20160178637
2016-06-23

DETECTION OF ALPHA, BETA-DICARBONYL COMPOUNDS WITH FLUOROGENIC PROBES

 #83
20160169922
2016-06-16

Methods for predicting risk of coronary stenosis

 #84
20160169893
2016-06-16

PCSK9 Function Assay

 #85
20160131664
2016-05-12

Method for risk stratification in stable coronary artery disease

 #86
20160131661
2016-05-12

PHOSPHORYLCHOLINE CONJUGATES AND CORRESPONDING ANTIBODIES

 #87
20160061846
2016-03-03

Method for evaluating atherosclerotic lesion, and kit

 #88
20160047811
2016-02-18

METHODS FOR ASSESSING THE RISK OF CARDIOVASCULAR DISEASE

 #89
20160018423
2016-01-21

NON-HIGH DENSITY LIPOPROTEIN DERIVED CVD MARKERS

 #90
20150346217
2015-12-03

USE OF sCD14 OR ITS FRAGMENTS OR DERIVATIVES FOR RISK STRATIFICATION, DIAGNOSIS AND PROGNOSIS

 #91
20150329591
2015-11-19

Azapeptides as CD36 binding compounds

 #92
20150301070
2015-10-22

Lipid biomarkers for stable and unstable heart disease

 #93
20150268231
2015-09-24

Immunoassay of S-adenosylmethionine in personalized medicine and health or cancer evaluation

 #94
20150247873
2015-09-03

Lipidomic biomarkers for atherosclerosis and cardiovascular disease

 #95
20150226749
2015-08-13

Method for measuring the level of circulating inhibitory factor 1 protein in a subject measuring the level of circulating inhibitory factor 1 (IF1) protein in a subject

 #96
20150196200
2015-07-16

Non-invasive method and system for detection of cancer or arterial vascular disorders using metal nanoparticles

 #97
20150177259
2015-06-25

Methods for treatment of cardiovascular disease

 #98
20150168428
2015-06-18

COMPOSITIONS AND METHODS FOR ASSESSING CARDIOVASCULAR DISEASE

 #99
20150160201
2015-06-11

Compositions and Methods for Detecting Unstable Arteriosclerotic Plaques

 #100
20150149094
2015-05-28

NMR quantification of TMAO

 #101
20150118698
2015-04-30

Biochemical markers for CVD risk assessment

 #102
20150118236
2015-04-30

Method for Predicting the Risk of Getting a Cardiovascular Event in a Female Subject

 #103
20150092999
2015-04-02

Determination of a fractional flow reserve (FFR) value for a stenosis of a vessel

 #104
20150087727
2015-03-26

Method for risk stratification in stable coronary artery disease

 #105
20150050675
2015-02-19

C1q-ADIPONECTIN COMPLEX AND USE THEREOF

 #106
20140377874
2014-12-25

Method for determining the propensity for calcification

 #107
20140377780
2014-12-25

Vascular Tumor Markers

 #108
20140371089
2014-12-18

METHOD FOR DIGANOSING ATHEROSCLEROTIC PLAQUES BY MEASUREMENT OF CD36

 #109
20140328763
2014-11-06

Bioactive amphiphilic polymer stabilized nanoparticles with enhanced stability and activity

 #110
20140309124
2014-10-16

Methods for assessing atherogenesis by determining oxidized phospholipid to apolipoprotein B ratios

 #111
20140295485
2014-10-02

Molecular flux rates through critical pathways measured by stable isotope labeling in vivo, as biomarkers of drug action and disease activity

 #112
20140295484
2014-10-02

Molecular flux rates through critical pathways measured by stable isotope labeling in vivo, as biomarkers of drug action and disease activity

 #113
20140255953
2014-09-11

Granzyme A and granzyme B diagnostics

 #114
20140193828
2014-07-10

Molecular flux rates through critical pathways measured by stable isotope labeling In Vivo, as biomarkers of drug action and disease activity

 #115
20140186838
2014-07-03

Molecular flux rates through critical pathways measured by stable isotope labeling in vivo, as biomarkers of drug action and disease activity

 #116
20140186360
2014-07-03

Phosphorylcholine conjugates and corresponding antibodies

 #117
20140134654
2014-05-15

Methods of measuring amount of cholesteryl ester in a blood sample

 #118
20140079638
2014-03-20

Conjugates of polymers having a therapeutically active agent and an angiogenesis targeting moiety attached thereto and uses thereof in the treatment of angiogenesis related diseases

 #119
20140037640
2014-02-06

Composition comprising expression or activity inhibitors of Ninjurin1 for the prevention and treatment of inflammatory disease

 #120
20130337472
2013-12-19

Cell division marker

 #121
20130325353
2013-12-05

NMR quantification of TMAO

 #122
20130317030
2013-11-28

Methods for treatment of cardiovascular disease

 #123
20130273579
2013-10-17

Method for analyzing proteins contributing to autoimmune diseases, and method for testing for said diseases

 #124
20130273533
2013-10-17

Molecular flux rates through critical pathways measured by stable isotope labeling in vivo, as biomarkers of drug action and disease activity

 #125
20130203686
2013-08-08

Azapeptides as CD36 binding compounds

 #126
20130203176
2013-08-08

Detection method

 #127
20130183691
2013-07-18

Polypeptide marker for diagnosis of arteriosclerosis, method for detection of arteriosclerosis by using the maker or the like, and kit for diagnosis of arteriosclerosis

 #128
20130131086
2013-05-23

Pharmaceutical compositions comprising GPR119 agonists which act as peptide YY (PYY) secretagogues

 #129
20130059771
2013-03-07

Composition comprising an angiopoietin-4 fragment

 #130
20130045217
2013-02-21

Lipidomic biomarkers for atherosclerosis and cardiovascular disease

 #131
20130040851
2013-02-14

Evaluation method for arteriosclerosis

 #132
20130023054
2013-01-24

Lipid biomarkers for stable and unstable heart disease

 #133
20130017562
2013-01-17

Assay for vascular calcification

 #134
20130017556
2013-01-17

ASSAYS FOR HDL BIOMOLECULAR INTERACTIONS

 #135
20130012603
2013-01-10

METHODS FOR ASSESSING THE RISK OF CARDIOVASCULAR DISEASE

 #136
20120311729
2012-12-06

Immunomodulatory methods and systems for treatment and/or prevention of atherosclerosis

 #137
20120264150
2012-10-18

Detection of restenosis risk in patients receiving a stent by measuring the characteristics of blood clotting including the measurement of maximum thrombin-induced clot strength

 #138
20120252867
2012-10-04

Method of therapy and diagnosis of atherosclerosis

 #139
20120195951
2012-08-02

Therapeutic Inhibitor of Vascular Smooth Muscle Cells

 #140
20120171194
2012-07-05

Method of Cell Differentiation and Uses Therefor in Screening, Diagnosis and Therapy

 #141
20120165211
2012-06-28

Human Antibodies Cross-Reacting With A Bacterial And A Self Antigen From Atherosclerotic Plaques

 #142
20120157397
2012-06-21

Trimethylamine-containing compounds for diagnosis and prediction of disease

 #143
20120149596
2012-06-14

METHODS FOR ASSESSING ATHEROGENESIS BY DETERMINING OXIDIZED PHOSPHOLIPID TO APOLIPOPROTEIN B RATIOS

 #144
20120129152
2012-05-24

Diagnostic method for the prediction of the development of and control over the effectiveness of treatment of cardiovascular illnesses

 #145
20120128660
2012-05-24

Diagnosis of restenosis in patients undergoing percutaneous coronary intervention

 #146
20120122242
2012-05-17

METHOD FOR ASSESSING ARTERIOSCLEROSIS AND DIABETIC NEPHROPATHY

 #147
20120122233
2012-05-17

Method for risk stratification in stable coronary artery disease

 #148
20120121605
2012-05-17

Anti sulfatides and anti sufated proteoglycans antibodies and their use

 #149
20120115127
2012-05-10

Molecular flux rates through critical pathways measured by stable isotope labeling in vivo, as biomarkers of drug action and disease activity

 #150
20120077708
2012-03-29

Beta-2 microglobulin as a biomarker for peripheral artery disease

 #151
20120052068
2012-03-01

AUTOPHILIC ANTIBODIES AND METHOD OF MAKING THE SAME

 #152
20120045774
2012-02-23

Lipoprotein Associated Phospholipase A2, Inhibitors Thereof and Use of the Same in Diagnosis and Therapy

 #153
20120039895
2012-02-16

PHOSPHORYCHOLINE CONJUGATES AND CORRESPONDING ANTIBODIES

 #154
20120035074
2012-02-09

Methods to determine atherosclerosis regression, plaque stabilization and cardiovascular risk

 #155
20120034629
2012-02-09

PREDICTION OF NON-FATAL AND FATAL ATHEROTHROMBOTIC EVENTS

 #156
20120028881
2012-02-02

METHODS AND REAGENTS FOR DIAGNOSING ATHEROMA

 #157
20120004133
2012-01-05

METHOD FOR THE DIAGNOSIS OF AGE-ASSOCIATED VASCULAR DISORDERS

 #158
20120003151
2012-01-05

METHOD FOR EARLY IMAGING OF ATHEROSCLEROSIS

 #159
20110312874
2011-12-22

Improving vascular function with an inactivating mutant of a TRPC channel protein

 #160
20110300221
2011-12-08

Therapeutic Inhibitor of Vascular Smooth Muscle Cells

 #161
20110287955
2011-11-24

POLYPEPTIDE MARKER FOR DIAGNOSIS OF ARTERIOSCLEROSIS, METHOD FOR DETECTION OF ARTERIOSCLEROSIS BY USING THE MAKER OR THE LIKE, AND KIT FOR DIAGNOSIS OF ARTERIOSCLEROSIS

 #162
20110286923
2011-11-24

Conjugates of polymers having a therapeutically active agent and an angiogenesis targeting moiety attached thereto and uses thereof in the treatment of angiogenesis related diseases

 #163
20110280887
2011-11-17

Methods for treatment of cardiovascular disease

 #164
20110262961
2011-10-27

Diagnosis, prevention and treatment of disorders characterized by undesirable cell proliferation

 #165
20110250193
2011-10-13

Composition comprising expression or activity inhibitors of ninjurin1 for the prevention and treatment of inflammatory disease

 #166
20110229885
2011-09-22

Methods and Compositions for Determining Predisposition to Inflammation-Mediated Cardiovascular Disease

 #167
20110223626
2011-09-15

Method, reagent and kit for measuring cholesterol in low-density lipoproteins

 #168
20110223617
2011-09-15

IMMUNOASSAYS FOR AUTOANTIBODIES IN CARDIOVASCULAR DISEASES

 #169
20110212477
2011-09-01

Lipoprotein-associated markers for cardiovascular disease

 #170
20110212471
2011-09-01

METHOD FOR DIAGNOSING ATHEROSCLEROTIC PLAQUES BY MEASUREMENT OF CD36

 #171
20110189086
2011-08-04

Diagnostic method for atherosclerosis

 #172
20110182817
2011-07-28

Antibody against calcified globule and use of the same

 #173
20110182816
2011-07-28

Antibody against oxidized LDL/βGPI complex and use of the same

 #174
20110177610
2011-07-21

NOVEL MARKER FOR ARTERIOSCLEROTIC DISEASE

 #175
20110165173
2011-07-07

THERAPEUTIC AGENT AND DETECTION REAGENT FOR ARTERIOSCLEROTIC DISEASE WHICH TARGETS FOR SALUSIN

 #176
20110152112
2011-06-23

DIAGNOSIS AND TREATMENT OF REVERSE CHOLESTEROL TRANSPORT DEFICIENCY-RELATED DISEASES

 #177
20110151481
2011-06-23

Beta-2 microglobulin as a biomarker for peripheral artery disease

 #178
20110142850
2011-06-16

Method of treating CD40-mediated diseases

 #179
20110117573
2011-05-19

Cell division marker

 #180
20110082349
2011-04-07

MEANS AND METHODS FOR DETERMINING THE ARTERIOSCLEROTIC STENOSIS USING INFLAMMATORY BIOMARKERS

 #181
20110070601
2011-03-24

CLASSIFICATION OF INDIVIDUALS SUFFERING FROM CARDIOVASCULAR DISEASES ACCORDING TO SURVIVAL PROGNOSES AS FOUND BY MEASURING THE LEVELS OF BIOMARKER YKL-40

 #182
20110065199
2011-03-17

Atherosclerosis marker and use thereof

 #183
20110059103
2011-03-10

Future cardiac event biomarkers CCL3, CCL5 and CCL18

 #184
20110059011
2011-03-10

Diagnosis and treatment of diseased and damaged tissue

 #185
20110039282
2011-02-17

METHOD OF DETECTING CALCIFYING NANOPARTICLES AND SUSCEPTIBILITY TO CALCIFYING NANOPARTICLE INFORMATION

 #186
20110021377
2011-01-27

Treating cardiovascular disease with TRPC3 channel protein

 #187
20110020351
2011-01-27

Polypeptide ESDN, polynucleotides encoding the polypeptide, and utility of the polypeptide

 #188
20100331238
2010-12-30

Methods of screening for a compound that reduces atherogenesis

 #189
20100330044
2010-12-30

MESP1 AS A MASTER REGULATOR OF MULTIPOTENT CARDIOVASCULAR PROGENITOR SPECIFICATION AND USES THEREOF

 #190
20100323455
2010-12-23

Diagnostic assay for human matrix GLA-protein and its use as a biomarker

 #191
20100323380
2010-12-23

METHODS FOR DIAGNOSING BLOOD VESSEL REOCCLUSION

 #192
20100317038
2010-12-16

Granzyme A and granzyme B diagnostics

 #193
20100311089
2010-12-09

Compositions and methods for diagnosing patients with acute atherosclerotic syndrome

 #194
20100304424
2010-12-02

Diagnostic and therapeutic tools for diseases altering vascular function

 #195
20100297680
2010-11-25

METHODS FOR ASSESSING THE RISK FOR DEVELOPMENT OF CARDIOVASCULAR DISEASE

 #196
20100285517
2010-11-11

Trimethylamine compounds as risk predictors of cardiovascular disease

 #197
20100280104
2010-11-04

METHODS AND KITS FOR DIAGNOSIS AND TREATMENT OF CELL-CELL JUNCTION RELATED DISORDERS

 #198
20100273268
2010-10-28

DETERMINING ATHEROSCLEROTIC LOAD USING PLACENTAL GROWTH FACTOR

 #199
20100261198
2010-10-14

Methods of detection of factor XIa and tissue factor

 #200
20100256196
2010-10-07

Biomarkers for Atherosclerosis

 #201
20100240029
2010-09-23

Cholesterol-Regulating Complex of SIRT1 and LXR and Methods of Use

 #202
20100226911
2010-09-09

Treating or preventing extracellular matrix build-up

 #203
20100226905
2010-09-09

PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING RESTENOSIS COMPRISING PEROXIREDOXIN 2 PROTEIN AS AN ACTIVE INGREDIENT AND COMPOSITION FOR SCREENING THERAPEUTICS OF RESTENOSIS COMPRISING PEROXIREDOXIN 2 GENE OR ITS PROTEIN PRODUCT, AND METHOD FOR SCREENING TH

 #204
20100210666
2010-08-19

METHODS OF USING A G PROTEIN-COUPLED RECEPTOR TO IDENTIFY PEPTIDE YY (PYY) SECRETAGOGUES AND COMPOUNDS USEFUL IN THE TREATMENT OF CONDITIONS MODULATED BY PYY

 #205
20100210566
2010-08-19

Azapeptides as CD36 binding compounds

 #206
20100209350
2010-08-19

Biomarkers for Adipose Tissue Activity

 #207
20100208290
2010-08-19

Deletion of unwanted reply messages in e-mail printing

 #208
20100203556
2010-08-12

Methods of using a G protein-coupled receptor to identify peptide YY (PYY) secretagogues

 #209
20100179066
2010-07-15

Method for Assessing the Risk of a Cardiovascular Disease and for Diagnosing Dyslipidemia

 #210
20100151585
2010-06-17

Method for determining degree of negative effect of macrophages on vertebrate

 #211
20100129927
2010-05-27

Peptides for Use in Diagnosing the Presence of Ruptured Atherosclerotic Lesions in a Individual

 #212
20100105088
2010-04-29

METHOD FOR DIAGNOSING ATHEROSCLEROTIC PLAQUES BY MEASUREMENT OF CD36

 #213
20100087362
2010-04-08

USE OF BIGLYCAN OR ENHANCERS OF BIGLYCAN ACTIVITY IN THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS

 #214
20100086944
2010-04-08

Methods and compositions for diagnosis and prognosis of renal artery stenosis

 #215
20100081149
2010-04-01

NOVEL OXIDIZED LDL COMPLEX AND METHOD FOR DETECTION THEREOF

 #216
20100062476
2010-03-11

ASSESSING MAMMALS FOR VASCULAR DISEASES AND VALVULAR DISEASES

 #217
20100056608
2010-03-04

METHODS FOR SCREENING AND TREATMENT INVOLVING THE GENES GYPC, AGPAT3, AGL, PVRL2, HMGB 3, HSDL2 AND/OR LDB2

 #218
20100028327
2010-02-04

Low density lipoprotein binding proteins and their use in diagnosing and treating atherosclerosis

 #219
20090324610
2009-12-31

GENE ASSOCIATED WITH ARTERIOSCLEROTIC DISEASE, AND USE THEREOF

 #220
20090318354
2009-12-24

Use of at least one isoform of progesterone receptor membrane component 1 (PGRMC1)

 #221
20090317846
2009-12-24

Method for detection of familial combined hyperlipidemia

 #222
20090317379
2009-12-24

AUTOPHILIC ANTIBODIES AND METHOD OF MAKING THE SAME

 #223
20090304769
2009-12-10

Methods for identifying agents and their use for the prevention of restenosis

 #224
20090304685
2009-12-10

Anti-Factor Xlla Therapy

 #225
20090280501
2009-11-12

A Method And A Kit For Diagnosing Type 2 Diabetes, Metabolic Syndrome, Sub Clinical Atherosclerosis, Myocardial Infarct, Stroke Or Clinical Manifestations Of Diabetes

 #226
20090253789
2009-10-08

Preventive/Remedy for Arteriosclerotic Disease and Method of Evaluating Therapeutic Procedure

 #227
20090253153
2009-10-08

Methods of using GPR119 to identify peptide YY (PYY) secretagogues and compounds useful in the treatment of conditions modulated by PYY

 #228
20090220990
2009-09-03

Method and kit for detecting condition in patient with disturbance of consciousness

 #229
20090214477
2009-08-27

Human Marker Genes and Agents for Diagnosis, Treatment and Prophylaxis of Cardiovascular Disorders and Artherosclerosis

 #230
20090198120
2009-08-06

Detection of restenosis risk in patients receiving a stent by measuring the characteristics of blood clotting including the measurement of maximum thrombin-induced clot strength

 #231
20090197806
2009-08-06

Adiponectin for treatment of various disorders

 #232
20090196931
2009-08-06

THERAPEUTIC INHIBITOR OF VASCULAR SMOOTH MUSCLE CELLS

 #233
20090192078
2009-07-30

Methods for diagnosis of cardiovascular disease

 #234
20090169473
2009-07-02

DIAGNOSTIC AGENT AND THERAPEUTIC AGENT FOR DISEASE ASSOCIATED WITH HEPATOCYTE GROWTH FACTOR RECEPTOR

 #235
20090162357
2009-06-25

Diagnosis, prevention, and/or treatment of atherosclerosis and underlying and/or related diseases

 #236
20090136969
2009-05-28

Lipoprotein Associated Phospholipase A2, Inhibitors Thereof and Use of the Same in Diagnosis and Therapy

 #237
20090130648
2009-05-21

Oxidized phospholipids

 #238
20090104705
2009-04-23

Ascorbic acid conjugates

 #239
20090104211
2009-04-23

Treatment of atherosclerosis

 #240
20090098570
2009-04-16

LXR ligand testing method

 #241
20090093396
2009-04-09

DIAGNOSTICS AND THERAPEUTICS FOR RESTENOSIS

 #242
20090093006
2009-04-09

Core 2 β(1,6)-acetylglycosaminyltransferase as diagnostic marker for atherosclerosis

 #243
20090074740
2009-03-19

Use of haptoglobin genotyping in diagnosis and treatment of defective reverse cholesterol transport (RCT)

 #244
20090074663
2009-03-19

Peptide for diagnosing, preventing and treating atherosclerosis and uses thereof

 #245
20090028793
2009-01-29

Vascular Tumor Markers

 #246
20090010847
2009-01-08

Connective Tissue Growth Factor-4

 #247
20080318835
2008-12-25

Novel Integrin Ligand ITGL-TSP

 #248
20080313751
2008-12-18

Method by Using Human or Mice-Isg12 to Develop and Prepare Drugs and Single Nucleotide Polymorphism in the Isg12 Gene for Diagnostic Use

 #249
20080280376
2008-11-13

Method of evaluation of the relative risk of developing atherosclerosis in patients

 #250
20080279925
2008-11-13

Method(s) of preventing, arresting, reversing and treatment of atherosclerosis

 #251
20080268478
2008-10-30

Use of Eotaxin as a Diagnostic Indicator For Atherosclerosis and Vascular Inflammation

 #252
20080267909
2008-10-30

PHAGOCYTE ENHANCEMENT THERAPY FOR ATHEROSCLEROSIS

 #253
20080261250
2008-10-23

Methods for assessing the risk for development of cardiovascular disease

 #254
20080248505
2008-10-09

Detection of Lipid Oxidising Abzymes in Samples

 #255
20080221025
2008-09-11

Use of Trpc Channel for the Treatment of a Cardiovascular Disease

 #256
20080188387
2008-08-07

Direct Assay of Skin Protein in Skin Samples Removed by Tape Stripping

 #257
20080171396
2008-07-17

Panel of biomarkers for peripheral arterial disease

 #258
20080169194
2008-07-17

Polypeptide Marker for the Diagnosis of Ateriosclerosis

 #259
20080166721
2008-07-10

Methods and compositions for determining predisposition to inflammation-mediated cardiovascular disease

 #260
20080160562
2008-07-03

Method for assessing arteriosclerosis and diabetic nephropathy

 #261
20080153115
2008-06-26

Compositions and methods for diagnosing patients with acute atherosclerotic syndrome

 #262
20080118924
2008-05-22

USE OF NATRIURETIC PEPTIDES AS DIAGNOSTIC AND PROGNOSTIC INDICATORS IN VASCULAR DISEASES

 #263
20080058360
2008-03-06

Soluble CD40L (CD 154) as a prognostic marker of atherosclerotic diseases

 #264
20080033150
2008-02-07

Assays, antibodies, and standards for detection of oxidized and MDA-modified low density lipoproteins

 #265
20080026412
2008-01-31

Beta-2 microglobulin as a biomarker for peripheral artery disease

 #266
20080025970
2008-01-31

Treatment of atherosclerosis

 #267
20070292406
2007-12-20

Pharmaceutical composition for preventing and treating restenosis comprising peroxiredoxin 2 protein as an active ingredient and composition for screening therapeutics of restenosis comprising peroxiredoxin 2 gene or its protein product, and method for screening therapeutics of restinosis using said composition

 #268
20070286868
2007-12-13

Phosphorylcholine conjugates and corresponding antibodies

 #269
20070264677
2007-11-15

Methods, systems and computer programs for assessing CHD risk using adjusted HDL particle number measurements

 #270
20070259388
2007-11-08

Assays, antibodies, and standards for detection of oxidized and MDA-modified low density lipoproteins

 #271
20070258902
2007-11-08

Method for assessing atherosclerosis by measuring expression of FOS or DUSP1 in monocytes

 #272
20070253901
2007-11-01

Atherosclerosis genes and related reagents and methods of use thereof

 #273
20070249006
2007-10-25

Assays, antibodies, and standards for detection of oxidized and MDA-modified low density lipoproteins

 #274
20070248591
2007-10-25

Preventive/Therapeutic Drug for Arteriosclerosis

 #275
20070224121
2007-09-27

Connective Tissue Growth Factor-4

 #276
20070218501
2007-09-20

Assays to predict atherosclerosis and dysfunctional high-density lipoprotein

 #277
20070202554
2007-08-30

Method for determining degree of negative effect of macrophages on vertebrate

 #278
20070190586
2007-08-16

Detection and determination of the stages of coronary artery disease

 #279
20070185020
2007-08-09

Methods and compositions for treating disorders of the extracellular matrix

 #280
20070178438
2007-08-02

Methods of diagnosing atherosclerosis by measuring ApoCI

 #281
20070172892
2007-07-26

Polypeptide ESDN, polynucleotides encoding the polypeptide, and utility of the polypeptide

 #282
20070154957
2007-07-05

Cell division marker

 #283
20070148779
2007-06-28

Multidimensional mass spectrometry or serum and celluar lipids directly from biologic extracts

 #284
20070148207
2007-06-28

Therapeutic inhibitor of vascular smooth muscle cells

 #285
20070141632
2007-06-21

Methods of treating cancer, arthritis and/or diabetes with angiopoietins

 #286
20070141625
2007-06-21

Method for assessing risk of and predisposition to development of a pathology related to the presence of anti-epcr autoantibodies

 #287
20070134314
2007-06-14

Therapeutic inhibitor of vascular smooth muscle cells

 #288
20070111258
2007-05-17

Compositions and methods for modulating the acute phase response

 #289
20070099242
2007-05-03

Lipoprotein-associated markers for cardiovascular disease

 #290
20070099229
2007-05-03

Marburg I mutant of factor VII activating protease (FSAP) as risk factor for arterial thrombosis and methods of detecting FSAP and FSAP mutations

 #291
20070077251
2007-04-05

Lipoprotein associated phospholipase A2, inhibitors thereof and use of the same in diagnosis and therapy

 #292
20070038386
2007-02-15

Computer systems and methods for inferring casuality from cellular constituent abundance data

 #293
20070027084
2007-02-01

Novel Integrin Ligand ITGL-TSP

 #294
20070026495
2007-02-01

Novel Integrin Ligand ITGL-TSP

 #295
20060241869
2006-10-26

Computer systems and methods for inferring causality from cellullar constituent abundance data

 #296
20060234297
2006-10-19

Screening method

 #297
20060199268
2006-09-07

Method for assessing arteriosclerosis and diabetic nephropathy

 #298
20060183245
2006-08-17

Prevention and treatment of atherosclerosis by reducing carbamylation of LDL or the effects of carbamylated LDL

 #299
20060177435
2006-08-10

Methods for assessing atherogenesis by determining oxidized phospholipid to apolipoprotein B ratios

 #300
20060172429
2006-08-03

Methods of identification of biomarkers with mass spectrometry techniques